Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis

Globally, lung cancer is the leading cause of cancer-related deaths, primarily non-small cell lung cancer. Kirsten Rat Sarcoma Oncogene Homolog (KRAS) mutations are common in non-small cell lung cancer and linked to a poor prognosis. Covalent inhibitors targeting KRAS-G12C mutation have improved tre...

Descripción completa

Detalles Bibliográficos
Autor principal: Dodin, Yasmeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659610/
https://www.ncbi.nlm.nih.gov/pubmed/37986325
http://dx.doi.org/10.1097/MD.0000000000036084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659610/
https://www.ncbi.nlm.nih.gov/pubmed/37986325
http://dx.doi.org/10.1097/MD.0000000000036084

Ejemplares similares